Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL762401 | 0.83 | KMT2A (0.33) | ALDH1A1KMT2ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10798262 | 0.80 | LMNA (0.40) | ALDH1A1KMT2ALMNATAAR1TSHR | |
| SCHEMBL14583241 | 0.79 | ALDH1A1 (0.42) | ALDH1A1KMT2ALMNANPC1RAB9A | |
| SCHEMBL9873866 | 0.78 | HSD11B1 (0.48) | ALDH1A1KMT2ALMNANPC1RAB9A | |
| SCHEMBL9873869 | 0.78 | HSD11B1 (0.48) | ALDH1A1KMT2ALMNANPC1RAB9A | |
| SCHEMBL23698034 | 0.78 | LMNA (0.52) | ALDH1A1KMT2ALMNANPC1RAB9A | |
| SCHEMBL187221 | 0.78 | LMNA (0.52) | ALDH1A1KMT2ALMNANPC1RAB9A | |
| SCHEMBL14433686 | 0.78 | LMNA (0.52) | ALDH1A1KMT2ALMNANPC1RAB9A | |
| SCHEMBL3045980 | 0.78 | LMNA (0.52) | ALDH1A1KMT2ALMNANPC1RAB9A | |
| SCHEMBL1004125 | 0.78 | LMNA (0.52) | ALDH1A1KMT2ALMNANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070032433-A1 | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION CORVAS INTERNATIONAL, LTD. | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032433-A1 | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus | HPN, TMPRSS15, VIP | ALDH1A1 2369/4885KMT2A 3449/4885LMNA 3429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.